文献
J-GLOBAL ID:202202216320733451
整理番号:22A0910766
低用量ニボルマブおよびペンブロリズマブ投与の薬物動態学的シミュレーション解析:用量脱エスカレーションのための薬剤経済学的根拠【JST・京大機械翻訳】
Pharmacokinetic Simulation Analysis of Less Frequent Nivolumab and Pembrolizumab Dosing: Pharmacoeconomic Rationale for Dose Deescalation
著者 (7件):
Peer Cody J.
(Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA)
,
Heiss Brian L.
(Department of Medicine, Section of Hematology/Oncology, and Committee on Clinical Pharmacology & Pharmacogenomics, The University of Chicago, Chicago, Illinois, USA)
,
Goldstein Daniel A.
(Davidoff Cancer Center, Rabin Medical Center, Tel Aviv, Israel)
,
Goldstein Daniel A.
(Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel)
,
Goodell Jennifer C.
(Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA)
,
Figg William D.
(Clinical Pharmacology Program, National Cancer Institute, Bethesda, Maryland, USA)
,
Ratain Mark J.
(Department of Medicine, Section of Hematology/Oncology, and Committee on Clinical Pharmacology & Pharmacogenomics, The University of Chicago, Chicago, Illinois, USA)
資料名:
Journal of Clinical Pharmacology
(Journal of Clinical Pharmacology)
巻:
62
号:
4
ページ:
532-540
発行年:
2022年
JST資料番号:
B0350B
ISSN:
0091-2700
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)